Literature DB >> 33867709

Association of Oxidative Stress with Disease Activity and Damage in Systemic Lupus Erythematosus: A Cross Sectional Study from a Tertiary Care Centre in Southern India.

Sanjeev Shruthi1, Molly Mary Thabah1, Bobby Zachariah2, Vir Singh Negi3.   

Abstract

To study oxidative stress in systemic lupus erythematosus (SLE) by estimating serum oxidised LDL (OxLDL), 8-hydroxy-2'-deoxyguanosine (8-OHdG), malondialdehyde (MDA), and total anti-oxidant status and to correlate with SLE disease activity and disease damage. Eighty SLE patients satisfying the Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) 2012 criteria and 80 healthy controls were studied. Exclusion criteria were infections, renal insufficiency, other connective tissue diseases, drug-induced lupus, smoking, alcohol consumption. Disease activity was measured by SLE disease activity index-2 K (SLEDAI), disease damage was quantified by SLICC-Damage Index (SDI). Sera was tested for OxLDL, 8-OHdG, and total antioxidant status (TAS) by double-antibody sandwich ELISA; MDA measured by Colorimetric assay. Oxidative stress markers were compared between group1- controls, group 2-mildly active SLE (SLEDAI ≤ 5), group 3- moderate to highly active SLE (SLEDAI ≥ 6). SLE patients had significantly higher MDA, 8-OHdG and lower TAS when compared to healthy controls, while OxLDL was similar in the three groups. MDA, 8-OHdG were significantly higher, TAS lower in group 3 compared to group 2. MDA had positive correlation with SLEDAI, TAS negatively correlated with SLEDAI. SLE with neuropsychiatric manifestations, vasculitis, anti-sdDNA antibodies had higher MDA, MDA/TAS ratio. SLE patients with thrombocytopenia, and vasculitis had higher OxLDL. Only OxLDL was significantly higher in those patients who have SDI > 1. SLE patients have increased oxidative stress measured by increases in MDA, 8-OHdG, and lower total antioxidant status that was associated with disease activity and some disease manifestations. However only OxLDL was associated with damage. © Association of Clinical Biochemists of India 2020.

Entities:  

Keywords:  LDL; Malondialdehyde; Nephritis; Neuropsychiatric lupus; Oxidative stress; Oxidized

Year:  2020        PMID: 33867709      PMCID: PMC7994501          DOI: 10.1007/s12291-020-00879-5

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  39 in total

1.  Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity.

Authors:  Samia Z Hassan; Tamer A Gheita; Sanaa A Kenawy; Atef T Fahim; Iman M El-Sorougy; Manal S Abdou
Journal:  Int J Rheum Dis       Date:  2011-07-21       Impact factor: 2.454

2.  Oxidative stress promotes hypertension and albuminuria during the autoimmune disease systemic lupus erythematosus.

Authors:  Keisa W Mathis; Marcia Venegas-Pont; C Warren Masterson; Nicholas J Stewart; Katie L Wasson; Michael J Ryan
Journal:  Hypertension       Date:  2012-01-30       Impact factor: 10.190

3.  Increased mitochondrial electron transport chain activity at complex I is regulated by N-acetylcysteine in lymphocytes of patients with systemic lupus erythematosus.

Authors:  Edward Doherty; Zachary Oaks; Andras Perl
Journal:  Antioxid Redox Signal       Date:  2014-04-23       Impact factor: 8.401

Review 4.  Role of reactive aldehyde in cardiovascular diseases.

Authors:  K Uchida
Journal:  Free Radic Biol Med       Date:  2000-06-15       Impact factor: 7.376

5.  Antioxidants suppress mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE).

Authors:  S Suwannaroj; A Lagoo; D Keisler; R W McMurray
Journal:  Lupus       Date:  2001       Impact factor: 2.911

6.  Mitochondrial DNA damage is associated with damage accrual and disease duration in patients with systemic lupus erythematosus.

Authors:  L López-López; M Nieves-Plaza; M del R Castro; Y M Font; C A Torres-Ramos; L M Vilá; S Ayala-Peña
Journal:  Lupus       Date:  2014-06-04       Impact factor: 2.911

Review 7.  Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management.

Authors:  A Misra; P Chowbey; B M Makkar; N K Vikram; J S Wasir; D Chadha; Shashank R Joshi; S Sadikot; R Gupta; Seema Gulati; Y P Munjal
Journal:  J Assoc Physicians India       Date:  2009-02

8.  N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.

Authors:  Zhi-Wei Lai; Robert Hanczko; Eduardo Bonilla; Tiffany N Caza; Brandon Clair; Adam Bartos; Gabriella Miklossy; John Jimah; Edward Doherty; Hajra Tily; Lisa Francis; Ricardo Garcia; Maha Dawood; Jianghong Yu; Irene Ramos; Ioana Coman; Stephen V Faraone; Paul E Phillips; Andras Perl
Journal:  Arthritis Rheum       Date:  2012-09

9.  Improvement in endothelial dysfunction in patients with systemic lupus erythematosus with N-acetylcysteine and atorvastatin.

Authors:  Jyothsna Kudaravalli
Journal:  Indian J Pharmacol       Date:  2011-05       Impact factor: 1.200

10.  Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes.

Authors:  L A Casciola-Rosen; G Anhalt; A Rosen
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.